The OPTION Clinical Trial

The OPTION Clinical Trial

What is the OPTION Clinical Trial?

The OPTION Clinical Trial is a randomized controlled trial comparing the safety and effectiveness of left atrial appendage closure (LAAC) to oral anticoagulation (OAC)
therapy for stroke protection in post-ablation patients with atrial fibrillation.

This study involves an investigational device called the WATCHMAN FLX™*.

Study Overview

The number of subjects expected to participate in the study will be 1600 at up to 130 investigational centers around the world. Below is an overview of the study.
OPTION Physician Site Diagram

* Caution: The WATCHMAN FLX™ Left Atrial Appendage Closure Device is an investigational device and is not available for sale in the U.S.

©2019 Boston Scientific Corporation or its affiliates. All rights reserved.